Honkarakenne (HONBS) H2 2021 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2021 earnings summary
12 Nov, 2026Executive summary
FY 2021 revenue rose 32% YoY to €69.7m; operating profit was €3.7m and EPS €0.56. Year-end order book reached a record €52.4m.
Profitability improved overall, but weakened toward year-end as raw-material inflation and supply disruptions increased production and delivery costs.
Financial highlights
Revenue was €69.7m vs €52.9m in 2020; operating profit €3.7m vs €3.1m; profit before tax €3.6m vs €2.9m.
Net profit was €3.303m vs €2.814m; basic and diluted EPS were €0.56 vs €0.48.
No non-recurring adjustment items in 2021; 2020 included €0.3m of production reorganisation costs. Adjusted operating profit was €3.7m vs €3.4m; adjusted PBT €3.6m vs €3.2m.
Operating cash flow was €7.2m vs €6.0m; inventories rose to €6.5m from €4.6m and customer advances to €10.8m from €6.6m.
Outlook and guidance
FY 2022 revenue and profit before taxes are expected to remain at FY 2021 levels; outlook is based on the order book, market recovery, input-cost trends and strategy actions.
Order book at December-end was a record €52.4m, up 32% YoY; orders generally carry delivery dates within 24 months and may be subject to financing or permit conditions.
Latest events from Honkarakenne
- Finland growth lifted sales, but Russia’s exit and softer demand cloud the 2023 outlook. citeturn0search0HONBS
H2 2022 - Sales fell 37%; FY24 guidance sees €43–50m sales and operating profit up to €0.5m.HONBS
H2 2023 - Order book up 28% year-over-year, with improved operational EBIT and positive 2026 outlook.HONBS
H1 2026 - Net sales rose slightly, but profitability declined; order book and 2026 outlook improved.HONBS
H2 2025 - Net sales up 15% year-over-year, but profitability remains negative amid market challenges.HONBS
H1 2025 - Net sales dropped 37% and operating profit turned negative, but the order book rebounded 44%.HONBS
H1 2024 - Net sales declined sharply but order book and financial position remain robust for 2025.HONBS
H2 2024